UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant þ
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement |
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
¨ | Definitive Proxy Statement |
þ | Definitive Additional Materials |
¨ | Soliciting Material Pursuant to Section 240.14a-12 |
| ||
(Name of Registrant as Specified In Its Charter) | ||
| ||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||
Payment of Filing Fee (Check the appropriate box): | ||
þ No fee required. | ||
¨ Fee computed on the table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||
(1) | Title of each class of securities to which transaction applies:
| |
| ||
(2) | Aggregate number of securities to which transaction applies:
| |
| ||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |
| ||
(4) | Proposed maximum aggregate value of transaction:
| |
| ||
(5) | Total fee paid: | |
| ||
¨ Fee paid previously with preliminary materials. | ||
¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||
(1) | Amount Previously Paid:
| |
| ||
(2) | Form, Schedule or Registration Statement No.:
| |
| ||
(3) | Filing Party:
| |
| ||
(4) | Date Filed:
| |
|
*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 13, 2012.
Meeting Information | ||||||||
Meeting Type: | Annual Meeting | |||||||
CELGENE CORPORATION | For holders as of: | April 18, 2012 | ||||||
Date: June 13, 2012 | Time: 1:00 PM EDT | |||||||
Location: Celgene Corporation | ||||||||
Company Offices | ||||||||
86 Morris Avenue Summit, NJ 07901
Meeting Directions: For directions to the Annual Meeting, please call Investor Relations at (908) 673-9000.
|
CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT, NJ 07901 |
You are receiving this communication because you hold shares in Celgene Corporation.
| |||
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). | ||||
We encourage you to access and review all of the important information contained in the proxy materials before voting.
|
See the reverse side of this notice to obtain proxy materials and voting instructions. |
M46409-P18838
Before You Vote |
||||||||
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE: | ||
Annual Report to Shareholders, including Annual Report on Form 10-K, Notice of Annual Meeting of Stockholders and Proxy Statement.
How to View Online: Have the information that is printed in the box marked by the arrow ® XXXX XXXX XXXX (located on the following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET: www.proxyvote.com 2) BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow ® XXXX XXXX XXXX (located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 30, 2012 to facilitate timely delivery.
|
How To Vote |
||||||||
Please Choose One of the Following Voting Methods
Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow ® XXXX XXXX XXXX available and follow the instructions.
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
M46410-P18838
Voting Items | ||||||
The Board of Directors recommends you vote FOR the following: |
||||||
1. Election Of Directors |
||||||
Nominees: |
||||||
01) Robert J. Hugin |
06) Michael A. Friedman, M.D. | |||||
02) Richard W. Barker, D. Phil. |
07) Gilla Kaplan, Ph.D. | |||||
03) Michael D. Casey |
08) James J. Loughlin | |||||
04) Carrie S. Cox |
09) Ernest Mario, Ph.D. | |||||
05) Rodman L. Drake |
||||||
The Board of Directors recommends you vote FOR proposals 2, 3 and 4: | ||||||
2. Ratification of the appointment of KPMG LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2012. |
||||||
3. Approval of an amendment to the Companys 2008 Stock Incentive Plan. |
||||||
4. Approval, by non-binding vote, of executive compensation of the Companys named executive officers. |
||||||
The Board of Directors recommends you vote AGAINST proposal 5: | ||||||
5. Stockholder proposal described in more detail in the proxy statement. |
||||||
NOTE: The shares represented by this proxy when properly executed will be voted in the manner directed herein by the undersigned Stockholder(s). If no direction is made, this proxy will be voted FOR the nominees for the Board of Directors listed in item 1, FOR items 2, 3 and 4, and AGAINST item 5. |
M46411-P18838
M46412-P18838